Even with getting made for less than $5 a month, copyright carries a retail price which is not easy to justify. The significant gap involving production expenses and pricing raises critical questions on the pharmaceutical business's pricing tactics.Novo Nordisk is linked to govt funded collaborative research projects with other industrial and gover